‘It’s literally giving them a solution in their hands’: the views of young Australians towards patient-delivered partner therapy for treating chlamydia

Layton, Elly; Goller, Jane L; Coombe, Jacqueline; Temple-Smith, Meredith; Tomnay, Jane; Vaisey, Alaina; Hocking, Jane

doi:10.1136/sextrans-2020-054820

Cited by 2 publications

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Hong Kong, this is currently not available or routinely prescribed. However, there is evidence that PDPT is valued by patients32 and can reduce reinfection rates 12. Given the recommendation to strengthen chlamydia management11 and the high likelihood of reinfection, further explorations to implement PDPT in Hong Kong may be warranted, including its acceptability to clinicians.…”

Section: Discussionmentioning

confidence: 99%

Preferences for chlamydia testing and management in Hong Kong: a discrete choice experiment

et al. 2021

Self Cite

View full text Add to dashboard Cite

ObjectivesAs most chlamydia cases are asymptomatic, regular testing and timely management may be necessary for control. We aimed to determine the preferences of people living in Hong Kong for chlamydia testing and management services.MethodsAn online panel of sexually active individuals living in Hong Kong completed the survey with two discrete choice experiments (DCEs). The first DCE examined the preferred attributes of a chlamydia testing service (cost, location, appointment time, speed of results, delivery of results and availability of other STI testing). The second DCE examined the preferred attributes of a chlamydia management service (cost, access to patient-delivered partner therapy, location, travel time, type of person consulted and attitude of staff).ResultsIn total, 520 individuals participated: average age 36.8 years (SD 9.9), 40% males and 66% had a bachelor’s degree or higher. Choosing to test was most influenced by cost, followed by speed of results, delivery of results, extra STI testing, appointment available and the least important was the location of testing. Choosing to attend for management was most influenced by staff’s attitude, followed by cost, who they consult, access to patient-delivered partner therapy, travel time and the least important was treatment location.ConclusionTo design effective chlamydia testing and management services, it is vital to respond to patient needs and preferences. For people living in Hong Kong, cost and staff attitude were the most important factors for deciding whether to test or be managed for chlamydia, respectively.

show abstract

Section: Discussionmentioning

confidence: 99%

Preferences for chlamydia testing and management in Hong Kong: a discrete choice experiment

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

Determinants and prediction of Chlamydia trachomatis re-testing and re-infection within 1 year among heterosexuals with chlamydia attending a sexual health clinic

Chow

Fairley

et al. 2023

Front. Public Health

View full text Add to dashboard Cite

BackgroundChlamydia trachomatis (chlamydia) is one of the most common sexually transmitted infections (STI) globally, and re-infections are common. Current Australian guidelines recommend re-testing for chlamydia 3 months after treatment to identify possible re-infection. Patient-delivered partner therapy (PDPT) has been proposed to control chlamydia re-infection among heterosexuals. We aimed to identify determinants and the prediction of chlamydia re-testing and re-infection within 1 year among heterosexuals with chlamydia to identify potential PDPT candidates.MethodsOur baseline data included 5,806 heterosexuals with chlamydia aged ≥18 years and 2,070 re-tested for chlamydia within 1 year of their chlamydia diagnosis at the Melbourne Sexual Health Center from January 2, 2015, to May 15, 2020. We used routinely collected electronic health record (EHR) variables and machine-learning models to predict chlamydia re-testing and re-infection events. We also used logistic regression to investigate factors associated with chlamydia re-testing and re-infection.ResultsAbout 2,070 (36%) of 5,806 heterosexuals with chlamydia were re-tested for chlamydia within 1 year. Among those retested, 307 (15%) were re-infected. Multivariable logistic regression analysis showed that older age (≥35 years old), female, living with HIV, being a current sex worker, patient-delivered partner therapy users, and higher numbers of sex partners were associated with an increased chlamydia re-testing within 1 year. Multivariable logistic regression analysis also showed that younger age (18–24 years), male gender, and living with HIV were associated with an increased chlamydia re-infection within 1 year. The XGBoost model was the best model for predicting chlamydia re-testing and re-infection within 1 year among heterosexuals with chlamydia; however, machine learning approaches and these self-reported answers from clients did not provide a good predictive value (AUC < 60.0%).ConclusionThe low rate of chlamydia re-testing and high rate of chlamydia re-infection among heterosexuals with chlamydia highlights the need for further interventions. Better targeting of individuals more likely to be re-infected is needed to optimize the provision of PDPT and encourage the test of re-infection at 3 months.

show abstract

‘It’s literally giving them a solution in their hands’: the views of young Australians towards patient-delivered partner therapy for treating chlamydia

Cited by 2 publications

References 21 publications

Preferences for chlamydia testing and management in Hong Kong: a discrete choice experiment

Preferences for chlamydia testing and management in Hong Kong: a discrete choice experiment

Determinants and prediction of Chlamydia trachomatis re-testing and re-infection within 1 year among heterosexuals with chlamydia attending a sexual health clinic

Contact Info

Product

Resources

About